Back to Search
Start Over
Corticotropin-releasing hormone, corticotropin-releasing hormone–binding protein, and activin A in maternal serum: Prediction of preterm delivery and response to glucocorticoids in women with symptoms of preterm labor
- Source :
- American Journal of Obstetrics and Gynecology. 183:643-648
- Publication Year :
- 2000
- Publisher :
- Elsevier BV, 2000.
-
Abstract
- The aim of this study was to determine prospectively whether serum concentrations of corticotropin-releasing hormone, corticotropin-releasing hormone-binding protein, and activin A (1) predict preterm birth within 10 days of hospital admission or at37 weeks' gestation among women with symptoms of preterm labor and (2) are affected by glucocorticoid therapy.Serum concentrations of corticotropin-releasing hormone and activin A were measured in 94 women with symptoms of preterm labor between 24 and 34 weeks' gestation, and delivery outcomes were monitored. Corticotropin-releasing hormone-binding protein concentrations were measured in 71 of these women. In a subgroup of 15 women the serum analytes were assayed in conjunction with estriol before and 12 to 24 hours after administration of dexamethasone.Forty-six percent (6/13) of the women who were delivered within 10 days of hospital admission had a raised serum corticotropin-releasing hormone level, but the predictive relationship was not significant (chi(2) = 1.7; P =.2). Among the 31 women (including the 6 previously mentioned) who were delivered at37 weeks' gestation, 39% (12/31) had a raised corticotropin-releasing hormone level. Although a raised corticotropin-releasing hormone concentration was positively associated with delivery at37 weeks' gestation (chi(2) = 9; P =.003), the predictive diagnostic value was poor, with sensitivity, specificity, and positive and negative predictive values of 39%, 90%, 67%, and 75%, respectively. The serum concentrations of corticotropin-releasing hormone-binding protein and activin A were unrelated to gestational age at delivery. Dexamethasone markedly lowered the serum estriol level (P.001) but had no effect on concentrations of corticotropinreleasing hormone, corticotropin-releasing hormone-binding protein, and activin A.Serum concentrations of corticotropin-releasing hormone, corticotropin-releasing hormone-binding protein, and activin A are not clinically useful for the prediction of preterm delivery among women with symptoms of preterm labor and are not affected by administration of glucocorticoids.
- Subjects :
- endocrine system
medicine.medical_specialty
Corticotropin-Releasing Hormone
Gestational Age
Dexamethasone
Corticotropin-releasing hormone
Obstetric Labor, Premature
Pregnancy
Internal medicine
Blood plasma
medicine
Humans
Inhibins
Prospective Studies
Glucocorticoids
Estriol
business.industry
Obstetrics and Gynecology
Gestational age
medicine.disease
Activins
Logistic Models
Endocrinology
Gestation
Female
Carrier Proteins
business
hormones, hormone substitutes, and hormone antagonists
Hormone
medicine.drug
Subjects
Details
- ISSN :
- 00029378
- Volume :
- 183
- Database :
- OpenAIRE
- Journal :
- American Journal of Obstetrics and Gynecology
- Accession number :
- edsair.doi.dedup.....e5a2c6c9ad86b936bfabffce1abb89f1
- Full Text :
- https://doi.org/10.1067/mob.2000.106592